How many vaccine doses does Covax aim to deliver by end-2021?

Question

Accepted Answer

Covax Aims to Deliver 2 Billion Vaccine Doses by End-2021

The Covax global vaccines facility is working towards delivering 2 billion doses of approved and effective Covid-19 vaccines by the close of 2021. This programme is a key component of the broader Access to Covid-19 Tools (ACT) Accelerator, which seeks to ensure equitable global access to essential pandemic response resources, including vaccines, treatments, and diagnostic tests.
Covax Programme Objectives

The primary objective of the Covax facility is to pool financial resources from wealthier nations and non-profit organisations to facilitate the development and equitable distribution of a Covid-19 vaccine worldwide. The programme is co-led by the World Health Organisation (WHO), the Gavi vaccine alliance, and the Coalition for Epidemic Preparedness Innovations (CEPI).
Global Funding and Participation

The ACT Accelerator, under which Covax operates, aims to secure approximately US$31 billion in funding from various non-profits and governments. As of the reporting period, the Covax facility had garnered interest from 92 lower-income countries seeking voluntary donations, alongside 80 wealthier nations that would financially support the initiative.
Concerns Regarding Vaccine Nationalism

The WHO has voiced significant concerns that wealthier countries securing large quantities of vaccines for their own populations could hinder global efforts to control the pandemic. WHO leadership has emphasised that a coordinated global distribution system, prioritising those most vulnerable, such as healthcare workers, is crucial for curbing the worldwide spread of the coronavirus.

Reading history

Hide →

This history is cleared when the page is closed.

How many vaccine doses does Covax aim to deliver by end-2021?

Loading

Was this article helpful?

Helpful

Not helpful

Report an issue

1

0

0

Share with friends